secwatch.observer — SEC 8-K summary
======================================

Issuer:     OptimizeRx Corp (OPRX)
CIK:        0001448431
Form:       8-K
Filed at:   2021-10-19T23:59:59+00:00
Accession:  0001213900-21-053525
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OptimizeRx CEO William Febbo gets $12.5M PRSU grant, base salary to $450k
-------------------------------------------------------------------------

- Base salary increased to $450,000 upon signing; annual target bonus raised to 100% of base salary.
- Granted $12.5M performance-based RSUs with three stock price milestones: 50%, 100%, 150% above base price of $65.91.
- PRSUs earned over five years; each milestone requires stock price >= target for 30 consecutive trading days; vesting on first anniversary of milestone date.
- RSU grant intended as CEO's only equity award for next five years, replacing annual grants; compensation committee may reconsider.
- Milestones set for compensation purposes only; not management projection.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1448431/000121390021053525/0001213900-21-053525-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1448431/000121390021053525/ea149083-8k_optimizerx.htm
  HTML page:      https://secwatch.observer/filing/0001213900-21-053525

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer